August 31, 2023 03:05 PM EDT
Pharma

Stop TB says the price of J&J's tu­ber­cu­lo­sis treat­ment be­daquiline drops 55%

Tyler Patchen

News Reporter

The Stop TB Part­ner­ship an­nounced a 55% de­crease in the price for John­son & John­son’s ver­sion of be­daquiline known as Sir­turo …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Take­da to pay $200M for rights to ane­mia drug from Keros

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

Rev­o­lu­tion sells $600M in shares on back of RAS in­hibitor port­fo­lio up­dates

Gilead makes an­oth­er ADC move, ink­ing up to $415M pact with Tubu­lis

Ipsen se­cures rights to pre­clin­i­cal T cell en­gager in $610M pact with French biotech

A service from the Financial Times